SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001354488-15-003575
Filing Date
2015-08-05
Accepted
2015-08-05 16:53:21
Documents
2
Period of Report
2015-06-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT AMENDMENT tbuff_8ka.htm 8-K/A 31959
2 CONSOLIDATED FINANCIAL STATEMENTS tbuff_ex994.htm EX-99.4 468037
  Complete submission text file 0001354488-15-003575.txt   501232
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31198 | Film No.: 151029640
SIC: 2834 Pharmaceutical Preparations